sodium hyaluronate gel
Commercial- Indications
- Ophthalmology, Orthopedics, Surgery
Company intelligence / Profile preview
The company has conducted at least one Phase 4 clinical trial (NCT02323451) comparing medical chitosan with sodium hyaluronate injection for knee osteoarthritis. Their chitosan nerve conduit has shown efficacy in repairing rat peripheral nerve defects with no significant difference compared to control groups in terms of histomorphology of regenerated nerve fibers and gastrocnemius muscle.[3]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Qisheng Biological Preparation Co., Ltd..